HF
FRTX

HRT Financial’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

HRT Financial’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-538
Closed -$6K – 3964
2022
Q1 		$6K Buy
538
+150
+39% +$1.62K ﹤0.01% 2949
2021
Q4 		$4K Buy
+388
New +$6.97K ﹤0.01% 3061
2021
Q2 		– Sell
-609
Closed -$29K – 3711
2021
Q1 		$29K Buy
+609
New +$33.4K ﹤0.01% 2581

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial's FRTX Position: Q2 2022 in Review

HRT Financial sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2022, closing a stake of 538 shares — an estimated $6K sold.

HRT Financial first reported a position in FRTX in Q1 2021 and held it in 3 quarters. The position peaked at $29K in Q1 2021. 22 funds tracked by Wall St. Rank hold FRTX as of Q2 2022.

  • HRT Financial reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • HRT Financial sold 538 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $6K.
  • HRT Financial first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • HRT Financial's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $29K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.